Found 50 matching trials
Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL)
PHASE4The purpose of this research study is to evaluate how effective ONTAK is in...
Location
City of Hope National Medical Center
A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
PHASE2Study of ONTAK and CHOP (chemotherapy drugs) to find out their ability to m...
Location
Birmingham Hematology and Oncology
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
PHASE2The purpose of this study is to look at the safety and effectiveness of ONT...
Location
Central Baptist Hospital
Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma
PHASE2RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Location
Mayo Clinic Scottsdale
ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment
PHASE1RATIONALE: ONTAK may be able to help reduce the type of cells that prevent ...
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Vaccination Plus Ontak in Patients With Metastatic Melanoma
PHASE2The purpose of this study is to determine if an experimental melanoma vacci...
Location
University of Chicago
Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma
NARATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Location
University of Miami Sylvester Comprehensive Cancer Center - Miami
E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma
PHASE1The purpose of this Phase 1 study is to determine the maximum tolerated dos...
Location
Multiple Locations
Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)
PHASE2The study is a randomized Phase II, four arm treatment trial. The primary p...
Location
City of Hope National Medical Center
Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients
PHASE4The purpose of this study is to provide an opportunity for patients who exh...
Location
University of Texas, M.D. Anderson Cancer Center